91 related articles for article (PubMed ID: 9302458)
1. Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
Antela A; Casado JL; González MJ; Pérez P; Pérez-Elías MJ; Montilla P; Buzón L
AIDS; 1997 Sep; 11(11):1405-6. PubMed ID: 9302458
[No Abstract] [Full Text] [Related]
2. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Scholten JN; Driver CR; Munsiff SS; Kaye K; Rubino MA; Gourevitch MN; Trim C; Amofa J; Seewald R; Highley E; Fujiwara PI
Clin Infect Dis; 2003 Dec; 37(12):1686-92. PubMed ID: 14689352
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
4. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
[TBL] [Abstract][Full Text] [Related]
5. Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.
Staszewski S; Haberl A; Gute P; Nisius G; Miller V; Carlebach A
Antivir Ther; 1998; 3 Suppl 4():55-6. PubMed ID: 10723511
[TBL] [Abstract][Full Text] [Related]
6. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
7. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
8. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
[TBL] [Abstract][Full Text] [Related]
9. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
[TBL] [Abstract][Full Text] [Related]
10. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
11. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
[TBL] [Abstract][Full Text] [Related]
12. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis in HIV-positive and HIV-negative drug users in Amsterdam].
Keizer ST; Langendam MW; van Deutekom H; Coutinho RA; van Ameijden FJ
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):184-9. PubMed ID: 9557024
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
Baklan Z; Gorisek JR; Poljak M; Pisec A
Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individuals.
Le TP; Tribble DR; Zhou SY; Malone L; Chung RC; Rusnak JM; Wagner KF
AIDS; 1997 Sep; 11(11):1395-6. PubMed ID: 9302451
[No Abstract] [Full Text] [Related]
16. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis treatment through directly observed therapy in a large multisite methadone maintenance treatment program: addressing the public health needs of a high-risk population.
Altarac D; Dansky SF
J Public Health Manag Pract; 1995; 1(4):40-7. PubMed ID: 10186640
[TBL] [Abstract][Full Text] [Related]
18. Treating drug misuse helps in HIV.
Weber R; Ledergerber B; Opravil M
Nurs Times; 1991 Jan 9-15; 87(2):10. PubMed ID: 1988910
[No Abstract] [Full Text] [Related]
19. The epidemiology of tuberculosis in patients with AIDS in Puerto Rico: morbidity and survival, 1981-1998.
Pérez-Perdomo R; Pérez-Cardona CM; Suárez-Pérez E
Int J Tuberc Lung Dis; 2000 Aug; 4(8):713-8. PubMed ID: 10949322
[TBL] [Abstract][Full Text] [Related]
20. [Patients with human immunodeficiency virus admitted to the emergency service of a general hospital].
Iglesias ML; Pedro-Botet J; Hernández E; Villalta R; Alvarez A; Gutiérrez J; Skaf E
Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):468-72. PubMed ID: 9527371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
